COc1ccc(/N=C2C(=N/c3ccc(OC)cc3)\N(c3ccc(N(C)C)cc3)C(=S)N\2c2ccc(OC)cc2)cc1
The rule of three is typically followed by orally active drugs, which have a molecular weight of <300, a c LogP of ≤3, a hydrogen bond donor count of ≤3 and a hydrogen bond acceptor count of ≤3. Does the molecule comply with the rule of three?